SPTX (Seaport Therapeutics) Accounts Payable: $2.01 Mil (As of Dec. 2025)


SPTX Seaport Therapeutics Inc SPTX
11 GF Score
Price $21.43
! 1 Warning Sign
View Full Analysis

What is Seaport Therapeutics Accounts Payable?

Seaport Therapeutics SPTX +10.37% 11 Accounts Payable is $2.01 Mil as of Dec. 2025. GuruFocus rates SPTX with a GF Score™ of 11/100. The stock has 1 warning sign investors should review.

Seaport Therapeutics's Accounts Payable for the quarter that ended in Dec. 2025 was $2.01 Mil.

Seaport Therapeutics's quarterly Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($4.73 Mil) but then declined from Dec. 2024 ($4.73 Mil) to Dec. 2025 ($2.01 Mil).

Seaport Therapeutics's annual Accounts Payable increased from . 20 ($0.00 Mil) to Dec. 2024 ($4.73 Mil) but then declined from Dec. 2024 ($4.73 Mil) to Dec. 2025 ($2.01 Mil).

Seaport Therapeutics Accounts Payable Related Terms

Seaport Therapeutics Accounts Payable Historical Data

* Premium members only.

The historical data trend for Seaport Therapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Seaport Therapeutics Accounts Payable Chart

Seaport Therapeutics Annual Data
Trend Dec24 Dec25
Accounts Payable
4.73 2.01

Seaport Therapeutics Semi-Annual Data
Dec24 Dec25
Accounts Payable 4.73 2.01
SPTX
11GF Score
Seaport Therapeutics Inc SPTX
Accounts Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Seaport Therapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Frequently Asked Questions Learn more about Accounts Payable →
What does a Accounts Payable of $2.01 Mil mean?
Seaport Therapeutics (SPTX) has a Accounts Payable of $2.01 Mil as of Dec. 2025. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Seaport Therapeutics and its competitors.
Is Seaport Therapeutics' Accounts Payable too high?
Seaport Therapeutics' current Accounts Payable is $2.01 Mil. Overall, Seaport Therapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Seaport Therapeutics' Accounts Payable compare to LXRX and DRTS?
Seaport Therapeutics' Accounts Payable of $2.01 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Accounts Payable for a Biotechnology company?
A good Accounts Payable depends on the Biotechnology industry context. However, Accounts Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Accounts Payable mean?
A high Accounts Payable can signal that a stock is expensive relative to its fundamentals. Accounts Payable is any money that a company owes for goods and services purchased on credit and is expected to pay within the next year. View historical data on Seaport Therapeutics and its competitors. Seaport Therapeutics's current Accounts Payable is $2.01 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Seaport Therapeutics stock overvalued right now?
Seaport Therapeutics (SPTX) has a current Accounts Payable of $2.01 Mil. The current Accounts Payable is $2.01 Mil. Seaport Therapeutics' overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Accounts Payable calculated?
Accounts Payable is calculated from a company's financial statements. For Seaport Therapeutics (SPTX), the current Accounts Payable is $2.01 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Seaport Therapeutics Business Description

Address 101 Seaport Boulevard, Floor 12, Boston, MA, USA, 02210
Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.
11GF Score

Get the complete analysis for SPTX

Accounts Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.43
Price